We recently reported interaction of a polymorphism with microRNA binding and downregulation of target gene expression as well as their correlation with tumor size and lymph node infiltration in estrogen receptor (ER)-negative breast cancer (Anwar et al., 2017). Here, ESR1 is linked to neoplasm.